Ramezan Ali  Ataee

Dr. Ramezan Ali Ataee


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2014 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
RRamezan Ali Ataee
Ramezan Ali Ataee
SHSamira Habibian
Samira Habibian
AMAli Mehrabi-Tavana
Ali Mehrabi-Tavana
ZAZyanab Ahmadi
Zyanab Ahmadi
NJNematollah Jonaidi
Nematollah Jonaidi
MSMahmood Salesi
Mahmood Salesi
In the context of growing health concerns over antibiotic resistance, the evaluation of the minimum inhibitory concentration (MIC) of vancomycin for Streptococcus pneumoniae (S. pneumoniae) strains resistant to ceftazidime becomes important for guiding health policy makers. The aim of this study was to determine vancomycin MIC of ceftazidime resistant S. pneumoniae strains. Fifty identified serotypes of ceftazidime resistant S. pneumoniae strains were included in the study. The vancomycin MIC of the above mentioned bacteria was determined based on the 0.5 McFarland standards, by using a microdilution broth and the Etest method. The results showed that out of 50 ceftazidime resistant strains of S. pneumoniae, 46 strains (92%) have shown a vancomycin MIC ≤0.19 − 0.1.5 μg/ml and only four strains (8%) have shown a vancomycin MIC equal to 1.5 μg/ml and the related maximum zone of inhibition was of 10 millimeter diameters. The results of this investigation point out the emergence of S. pneumoniae strains with a vancomycin MIC ≥1.5 μg/ml, which were resistant to ceftazidime. This finding uncovers a major health concern: a vancomycin MIC higher than 1.5 μg/ml and maximum zone of inhibition of only 10 millimeter. These findings represent an important warning for health authorities globally, concerning the treatment of patients, as the occurrence of S. pneumoniae strains with decreased vancomycin susceptibility has been demonstrated.


26 December 2015 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
RRamezan Ali Ataee
Ramezan Ali Ataee
RKReyhane Kashefi
Reyhane Kashefi
GAGholam Hossein Alishiri
Gholam Hossein Alishiri
DEDavoud Esmaieli
Davoud Esmaieli
Background: Rheumatoid arthritis (RA) is the most common chronic inflammatory disease. The staphylococcal superantigens are considered as the causative agent of RA disease. Objectives: This study aimed to assess the presence of staphylococcal enterotoxin D in synovial fluid and blood of patients with RA. Patients and Methods: A total of 120 blood and SF samples of patients with RA were studied. Bacterial culture, primer pairs design, polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay (ELISA) methods have been used to assess of the staphylococcal enterotoxin D. The data were analyzed through descriptive statistics. Results: During this study and after sequential subcultures, only 5 bacterial strains were isolated. The results of PCR showed the presence of staphylococcal enterotoxin D gene in almost 50% of SF and also in 48.4% of blood samples of patients with RA. Similarly, the ELISA method detected staphylococcal enterotoxin D in 36.16% of SF and in 33.33% of blood of patients with RA. Conclusions: The result of this study showed that a high percentage of patients with RA have shown staphylococcal enterotoxin D (superantigen D) or entD gene in SF and in blood. However, the origin of this superantigen was not clarified and no Staphylococcus aureus enterotoxin D producer was isolated. This finding indicates other role of this superantigen besides its intoxication. Therefore, staphylococcal enterotoxin D as a biomarker may provide a good model for the diagnosis and treatment of patients with RA. Keywords: Enterotoxin D; Staphylococcal; Superantigens; Arthritis; Rheumatoid; Polymerase Chain Reaction; Enzyme-Linked Immunosorbent Assay; Synovial Fluid

1 March 2023 in Iranian Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
NBNegin Bahmanpoor
Negin Bahmanpoor
SHSeyed Mohammad Mahdi Hamdi
Seyed Mohammad Mahdi Hamdi
RRamezan Ali Ataee
Ramezan Ali Ataee
Background and Aim: Pseudomonas aeruginosa exotoxins are responsible for pathogenicity and antibiotic resistant. The aim of this study was to investigate the effects of the Ammi. visnaga (A. visnaga) extract on the P. aeruginosa exotoxin A and S genes expression. Materials and Methods: Antibacterial effects of the A. visnaga ethanolic extract were performed using ...

1 July 2013 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
RRamezan Ali Ataee
Ramezan Ali Ataee
MHMojtaba Hedaiatich
Mojtaba Hedaiatich
RKRahim Mansuor Khanshan
Rahim Mansuor Khanshan
MAMohammad Hosein Ataee
Mohammad Hosein Ataee
Molecular Screening of Staphylococcal Enterotoxin Type P Encoding Gene From Clinical Isolates - Jundishapur Journal of Microbiology - - Kowsar

22 September 2019 in Iranian Journal of Microbiology
Verified
Journal Article
Open access
MBMahsa Banaei
Mahsa Banaei
GAGholam Hosein Alishiri
Gholam Hosein Alishiri
RRamezan Ali Ataee
Ramezan Ali Ataee
AMArdeshir Hesampoor Mahalati
Ardeshir Hesampoor Mahalati
Background and Objectives: Microbial superantigens have been reported in the blood and synovial fluid of rheumatoid arthritis patients, raising the question of whether the presence of these superantigens could provoke the induction of inflam- matory biomarkers expression or not. The purpose of this study was to examine the Staphylococcus aureus superantigen C on CD18 expression. Materials and Methods: The superantigen C was purified by ultrafiltration. Immunoblotting was performed using a specific antibody. Also, 50 micrograms of superantigens (toxin) were injected intraperitoneally and intra-articularly into separate rat groups. Blood was collected and RNA extracted. Then, the cDNA was synthesized. The expression of CD18 marker was evaluated using RT-real-time PCR, and the results were descriptively analyzed. Results: The results of this study revealed that 50 μg of toxin, injected intra-articularly and intraperitoneally, showed the surplus expression of the marker CD18 in the blood of rats after 20 days. By this method, the expression of the marker CD18 was significantly different between rats that received the superantigen intra-articularly and intraperitoneally (2.10; 2.3 and 3.3 folds) and the controls (P≤ 0.05). Conclusion: The results indicated that the presence of Staphylococcal of superantigen C in the body of rats has enhanced the expression of the CD18 inflammatory marker more than 3 times. This valuable finding is an introduction to further research and could provide new methods to prevent and control inflammatory diseases, including rheumatoid arthritis.